Are Generic Topical Prostanoids the Way Forward in the Care of Glaucoma Patients? - Yes
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
The Use of Generic Medications for Glaucoma.
Tatham A J Ophthalmol. 2020; 2020:1651265.
PMID: 32322409 PMC: 7166283. DOI: 10.1155/2020/1651265.
Patient experience of the transition from Xalatan to generic latanoprost.
Painter S, Mead A Eye (Lond). 2014; 28(7):911.
PMID: 24722506 PMC: 4094811. DOI: 10.1038/eye.2014.71.
References
1.
Fiscella R, Jensen M, Van Dyck G
. Generic prednisolone suspension substitution. Arch Ophthalmol. 1998; 116(5):703.
View
2.
Hargrave S, Jung J, Fini M, Gelender H, Cather C, Guidera A
. Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis. Ophthalmology. 2002; 109(2):343-50.
DOI: 10.1016/s0161-6420(01)00930-7.
View
3.
Roberts C, Nelson P
. Comparative analysis of prednisolone acetate suspensions. J Ocul Pharmacol Ther. 2007; 23(2):182-7.
DOI: 10.1089/jop.2006.0070.
View
4.
Narayanaswamy A, Neog A, Baskaran M, George R, Lingam V, Desai C
. A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension. Indian J Ophthalmol. 2007; 55(2):127-31.
DOI: 10.4103/0301-4738.30707.
View
5.
Takada Y, Okada Y, Fujita N, Saika S
. A patient with corneal epithelial disorder that developed after administration of a latanoprost generic, but not a brand-name drug, eye drop. Case Rep Ophthalmol Med. 2012; 2012:536746.
PMC: 3467777.
DOI: 10.1155/2012/536746.
View